Wells Fargo & Company Iridex Corp Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.35 - $3.1 $4 - $6	2 Added 2.08%	98 $0
Q4 2023 Feb 09, 2024	BUY	$1.9 - $3.28 $9 - $16	5 Added 5.49%	96 $0
Q3 2023 Nov 13, 2023	SELL	$1.33 - $2.54 $2 - $5	-2 Reduced 2.15%	91 $0
Q2 2023 Aug 15, 2023	BUY	$1.76 - $2.43 $5 - $7	3 Added 3.33%	93 $0
Q1 2023 May 12, 2023	BUY	$2.0 - $2.46 $4 - $4	2 Added 2.27%	90 $0
Q4 2022 Feb 13, 2023	BUY	$2.0 - $2.63 $6 - $7	3 Added 3.53%	88 $0
Q3 2022 Nov 14, 2022	SELL	$2.41 - $3.41 $4 - $6	-2 Reduced 2.3%	85 $0
Q2 2022 Aug 12, 2022	BUY	$2.48 - $4.66 $17 - $32	7 Added 8.75%	87 $0
Q4 2021 Feb 14, 2022	BUY	$5.62 - $9.37 $5 - $9	1 Added 1.27%	80 $0
Q3 2021 Nov 15, 2021	BUY	$6.29 - $7.98 $37 - $47	6 Added 8.22%	79 $1,000
Q4 2020 Feb 09, 2021	BUY	$1.62 - $2.91 $6 - $11	4 Added 5.8%	73 $0
Q3 2020 Nov 05, 2020	SELL	$1.78 - $2.51 $10 - $15	-6 Reduced 8.0%	69 $0
Q1 2020 May 14, 2020	BUY	$1.4 - $3.64 $105 - $273	75 New	75 $0

3.25M

500

61.3K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.